IMIDAPRIL

Search structure
Synonyms:
Status: Phase 3
Entry Type: Small molecule
Molecule Category: UNKNOWN
ATC: C09AA16
UNII: BW7H1TJS22

Structure
InChI Key KLZWOWYOHUKJIG-BPUTZDHNSA-N
Smile CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1C(=O)N(C)C[C@H]1C(=O)O
InChI
InChI=1S/C20H27N3O6/c1-4-29-19(27)15(11-10-14-8-6-5-7-9-14)21-13(2)17(24)23-16(18(25)26)12-22(3)20(23)28/h5-9,13,15-16,21H,4,10-12H2,1-3H3,(H,25,26)/t13-,15-,16-/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C20H27N3O6
Molecular Weight 405.45
AlogP 0.88
Hydrogen Bond Acceptor 6.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 9.0
Polar Surface Area 116.25
Molecular species ACID
Aromatic Rings 1.0
Heavy Atoms 29.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Angiotensin-converting enzyme inhibitor Other
Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Enzyme Protease Metallo protease Metallo protease MAE clan Metallo protease M2 family
- 9900 - - -

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Essential Hypertension 3 D000075222 ClinicalTrials
Polycystic Kidney, Autosomal Dominant 2 D016891 ClinicalTrials

Related Entries

MCS

Scaffolds

Cross References

Resources Reference
CAS NUMBER 89371-37-9
ChEBI 135654
ChEMBL CHEMBL317094
DrugBank DB11783
DrugCentral 1424
EPA CompTox DTXSID2048242
FDA SRS BW7H1TJS22
Human Metabolome Database HMDB0041907
Guide to Pharmacology 6377
PubChem 5464343
SureChEMBL SCHEMBL34098
ZINC ZINC000003784427
CONTENTS